Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

Background Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric condition
that may be related to an imbalance of neural transmitters. The gut microbiota is the largest …

Objectives: To evaluate the efficacy and safety of once-daily serdexmethylphenidate/
dexmethylphenidate (SDX/d-MPH) capsules (Azstarys™) compared with placebo in children …

In the last 15 years, there has been a marked increase in the number of available stimulant
formulations with the emphasis on long-acting formulations, and the introduction of several …

Background: ADHD (Attention-deficit/hyperactivity disorder) is a common
neurodevelopmental disorder that manifests itself during childhood with various …

Objectives: Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder
defined as a persistent pattern of inactivity and/or hyperactivity that interferes with behavioral …

Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral
disorder in childhood with an estimated prevalence in children aged 2 to 17 years of 6.1 …

ABSTRACT Introduction Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly
prevalent condition that causes persistent problems with attention and/or hyperactivity …

Objective: To compare the effect of a once-daily extended-release methylphenidate
formulation (PRC-063) versus placebo on sleep, measured via daily electronic diary in two …